Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZX77
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,021
Award facts
- Contract value 100% obligated
- $5,021.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on August 27, 2025, carries a ceiling value of $5,021.26 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. This award was made without a set-aside designation, demonstrating the contractor's competitive position in federal pharmaceutical procurement. The performance location is Park Ridge, Illinois.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and extending through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent performance on diverse product categories including branded and generic prescription drugs, biologics, and medical consumables. The EXPAREL product, a local anesthetic, represents the type of specialized pharmaceutical product the contractor regularly delivers to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FZX77?
SPE2DB25FZX77 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FZX77 worth?
The government has obligated $5,021 on SPE2DB25FZX77.
Is contract SPE2DB25FZX77 an order under another contract?
Yes. SPE2DB25FZX77 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX77 competed?
The extent of competition for SPE2DB25FZX77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award